The Valley Desk

ArticleClinical lung cancerPublished

Molecular Characteristics and Pretreatment Neutrophil-to-Lymphocyte Ratio as Predictors of Durable Clinical Benefit from Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple University, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Clinical lung cancer
Published
Subject terms
Neutrophils; Lymphocytes; Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Proto-Oncogene Proteins; Prognosis; Survival Rate; Retrospective Studies; Mutation; Adult; Aged
PubMed ID
38987048
PubMed Central ID
PMC11365775
Added to directory
Source checked

Report a correction or request removal